Voluntis gets FDA marketing approval for Oleena digital therapeutic

"Oleena is a care companion for the cancer patient journey based on mobile and web technologies Image: Oleena is a FDA class II software-as-a-medical device that can be used across all cancer indications. Digital therapeutics provider Voluntis has secured market authorisation from the US Food and Drug Administration (FDA) for its Oleena software for oncology-related symptoms management and remote patient monitoring. Claimed to be..." Lire la suite